Indianapolis

Running trials

• Recruiting

  A Study to Evaluate Mivelsiran in Adult Participants With Early-Stage Down Syndrome-Associated Alzheimer's Disease (DS-AD)

  NCT07636811· Phase 2· Source

• Recruiting

  Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation

  NCT07211958· Phase 3· Source

• Recruiting

  TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  NCT07052903· Phase 3· Source

• Active, not recruiting

  A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation

  NCT07023731· Phase 1/2· Source

• Enrolling by invitation

  A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  NCT06679946· Phase 3· Source

• Recruiting

  A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOAD

  NCT05231785· Phase 1· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease2 recruiting
• Amyloidosis2 recruiting
• Acute myeloid leukemia1 recruiting
• Childhood cancers1 recruiting

Researchers

No researcher is linked here yet.